Inovio Pharmaceuticals
INO
INO
125 hedge funds and large institutions have $143M invested in Inovio Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
22% less capital invested
Capital invested by funds: $182M → $143M (-$39.3M)
Holders
125
Holding in Top 10
1
Calls
$705K
Puts
$298K
Top Buyers
| 1 | +$2.39M | |
| 2 | +$2.28M | |
| 3 | +$1.21M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.18M |
| 5 |
BlackRock
New York
|
+$1.17M |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$1.47M | |
| 3 | -$482K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$440K |
| 5 |
KeyBank National Association
Cleveland,
Ohio
|
-$328K |